These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7048597)

  • 1. Mediation of cardiac ischemia by thromboxanes released from human platelets.
    Addonizio VP; Wetstein L; Fisher CA; Feldman P; Strauss JF; Harken AH
    Surgery; 1982 Aug; 92(2):292-8. PubMed ID: 7048597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-mediated cardiac ischemia.
    Addonizio VP; Wetstein L; Fisher CA; Feldman P; Strauss JF; Harken AH
    J Surg Res; 1982 Nov; 33(5):402-8. PubMed ID: 7132326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is cardiopulmonary bypass a reason for aspirin resistance after coronary artery bypass grafting?
    Zimmermann N; Kurt M; Wenk A; Winter J; Gams E; Hohlfeld T
    Eur J Cardiothorac Surg; 2005 Apr; 27(4):606-10. PubMed ID: 15784358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
    Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T
    Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2 is not involved in thromboxane biosynthesis by activated human platelets.
    Patrignani P; Sciulli MG; Manarini S; Santini G; Cerletti C; Evangelista V
    J Physiol Pharmacol; 1999 Dec; 50(4):661-7. PubMed ID: 10639016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of platelet and vascular eicosanoids in the pathophysiology of ischemic heart disease.
    Chierchia S; Patrono C
    Fed Proc; 1987 Jan; 46(1):81-8. PubMed ID: 3542579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MDA formation by platelets and plasmatic BTG levels in patients suffering from acute myocardial infarction (author's transl)].
    Davì G; Traina M; Novo S; Pinto A; Piraino GL; Marano G; Alfano R
    G Ital Cardiol; 1981; 11(9):1238-41. PubMed ID: 6173283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral heartache -- do platelets have a role?
    Handin RI; Alexander RW
    N Engl J Med; 1981 Apr; 304(17):1035-6. PubMed ID: 7010170
    [No Abstract]   [Full Text] [Related]  

  • 11. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspirin resistance and platelet turnover: a 25-year old issue.
    Di Minno G
    Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):542-5. PubMed ID: 21745731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duration of the effect of aspirin on the synthesis of thromboxane by density subpopulations of rabbit platelets stimulated with thrombin.
    Packham MA; Guccione MA; O'Brien KM
    Blood; 1985 Aug; 66(2):287-90. PubMed ID: 3926022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The platelet-perfused in-vitro heart: an alternative model for studying the role of endogenous prostacyclin and thromboxane in control of coronary perfusion.
    Köhler P; Schrör K
    Basic Res Cardiol; 1981; 76(5):463-7. PubMed ID: 7030300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutional thrombocytopathy with subnormal response to thromboxane A2.
    Samama M; Lecrubier C; Conard J; Hotchen M; Breton-Gorius J; Vargaftig B; Chignard M; Lagarde M; Dechavanne M
    Br J Haematol; 1981 Jun; 48(2):293-303. PubMed ID: 7195274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin-induced platelet inhibition in patients undergoing cardiac surgery.
    Zimmermann N; Kurt M; Winter J; Gams E; Wenzel F; Weber AA; Hohlfeld T
    Platelets; 2007 Nov; 18(7):528-34. PubMed ID: 17957569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in the suppression of platelet cyclooxygenase-1 activity by aspirin in coronary heart disease.
    Sciulli MG; Renda G; Capone ML; Tacconelli S; Ricciotti E; Manarini S; Evangelista V; Rebuzzi A; Patrignani P
    Clin Pharmacol Ther; 2006 Aug; 80(2):115-25. PubMed ID: 16890573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
    Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
    Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contributions of young platelets and of previously activated platelets to platelet reactivity in patients with coronary artery disease.
    Schneider DJ; Holmes CE; Taatjes-Sommer HS; Sobel BE
    Thromb Res; 2008; 121(4):455-62. PubMed ID: 17675221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.